Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: comparison between pre- and per-treatment studies

Radiotherapy and Oncology

Volumn 78, Issue 3, 2006, Pages 291-297

  Geets, Xavier ^a   Daisne, Jean Francois ^a   Tomsej, Milan ^a   Duprez, Thierry ^b   Lonneux, Max ^c   Grégoire, Vincent ^a  

^a Neck Oncology Program

^b Department of Radiology ^*

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Adaptive radiotherapy; CT scan; FDG PET; HNSCC; MRI; Multimodality imaging

Indexed keywords

FLUORODEOXYGLUCOSE;

ARTICLE; AUTOMATION; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; HUMAN; IMAGING; INFLAMMATION; INTENSITY MODULATED RADIATION THERAPY; IRRADIATION; LARYNX CARCINOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OROPHARYNX CARCINOMA; PAROTID GLAND; PHARYNX CARCINOMA; POSITRON EMISSION TOMOGRAPHY; PRACTICE GUIDELINE; PRIORITY JOURNAL; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; REGISTRATION; SQUAMOUS CELL CARCINOMA; STATISTICAL SIGNIFICANCE; TARGET ORGAN; TREATMENT PLANNING;

BODY BURDEN; CARCINOMA, SQUAMOUS CELL; FLUORODEOXYGLUCOSE F18; HUMANS; IMAGING, THREE-DIMENSIONAL; MAGNETIC RESONANCE IMAGING; PHARYNGEAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIATION INJURIES; RADIATION PROTECTION; RADIOMETRY; RADIOPHARMACEUTICALS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, CONFORMAL; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK ASSESSMENT; RISK FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 33645960650     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.radonc.2006.01.006     Document Type: Article

References (29)

1. Ahnesjö A., Saxner M., and Trepp A. A pencil beam for photons dose calculation. Med Phys 19 (1992) 263-273
2. Anzai Y., Minoshima S., Wolf G.T., and Wahl R.L. Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET. Radiology 212 (1999) 285-290
3. Barker J.L., Garden A.S., Dong L., et al. Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head and neck cancer using an integrated CT/linear accelerator system. Int J Radiat Oncol Biol Phys 59 (2004) 960-970
4. Chao K.S.C., Majhail N., Spector G., et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol 61 (2001) 275-280
5. Chao K.S.C., Ozygit G., Tran B.N., Cengiz M., Dempsey J., and Low D.A. Patterns of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. Int J Radiat Oncol Biol Phys 55 (2003) 312-321
6. Daisne J.F., Duprez T., Weynand B., et al. Comparison between CT scan, MRI and FDG-PET for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinomas: validation with the macroscopic surgical specimen. Radiology 233 (2004) 93-100
7. Daisne J.F., Sibomana M., Bol A., Cosnard G., Lonneux M., and Gregoire V. Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: precision, reproducibility and consistency. Radiother Oncol 69 (2003) 237-245
8. Daisne J.F., Sibomana M., Bol A., Doumont T., Lonneux M., and Gregoire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol 69 (2003) 247-250
9. Dawson L.A., Anzai Y., Marsh L., et al. Patterns of local-regional recurrence following parotid-sparing conformal and segmental intensity-modulated radiotherapy for head and neck cancer. Int J Radiat Oncol Biol Phys 46 (2000) 1117-1126
10. Eisbruch A., Marsh L.H., Wolf G.T., et al. Recurrences near base of skull after IMRT for head and neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys 59 (2004) 28-42
11. Eisbruch A., Ship J.A., Kim H.M., and Ten Haken R.K. Partial irradiation of the parotid gland. Semin Radiat Oncol 11 (2001) 234-239
12. Eisbruch A., ten haken R.K., Kim H.M., et al. Dose, volume and relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
13. Fogliata A., Bosli A., Cozzi L., and Bernier J. Comparative dosemetric evaluation of the simultaneous integrated boost with photon intensity modulation in head and neck cancer patients. Radiother Oncol 69 (2003) 267-275
14. Geets X., Daisne J.F., Gregoire V., Hamoir M., and Lonneux M. Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT. Radiother Oncol 71 (2004) 267-273
15. Gilbeau L., Octave-Prignot M., Loncol T., Renard L., Scalliet P., and Gregoire V. Comparison of setup accuracy of three different thermoplastic masks for the treatment of brain and head and neck tumors. Radiother Oncol 58 (2001) 155-162
16. Gregoire V. Is there any future in radiotherapy planning without the use of PET: unraveling the myth. Radiother Oncol 73 (2004) 261-263
17. Gregoire V., Daisne J.F., Geets X., and Levendag P. Selection and delineation of target volumes in head and neck tumors: beyond ICRU definition. Rays 28 (2003) 217-224
18. Gregoire V., and Maingon P. Intensity-modulated radiation therapy in head and neck squamous cell carcinoma: an adaptation of 2-dimensional concepts or a reconsideration of current clinical practice. Semin Radiat Oncol 14 (2004) 110-120
19. Jellema A.P., Doornaert P., Slotman B.J., Rene Leemans C., and Landendijk J.A. Does radiation dose to the salivary glands and oral cavity predict patient-rated xerostomia and sticky saliva in head-and-neck cancer patients treated with curative radiotherapy?. Radiother Oncol 77 (2005) 164-171
20. 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67 Ga Scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma. J Nucl Med 44 (2003) 198-206
21. Kubota R., Kubota K., Yamada S., Tada M., Ido T., and Tamahashi N. Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissue and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake. J Nucl Med 35 (1994) 104-112
22. Laprie A., Pirzkall A., Haas-Kogan D.A., et al. Longitudinal multi-voxel MR spectroscopy study of pediatric diffuse brain stem glioms treated with radiotherapy. Int J Radiat Oncol Biol Phys 62 (2005) 20-31
23. Leung L.H.T., Ooi G.C., Kwong D.L.W., et al. White matter diffusion anisotropy after chemo-irradiation: a statistical parametric mapping study and histogram analysis. Neuroimage 21 (2004) 261-268
24. Mohan R., Wu Q., Manning M., and Schmidt-Ullrich R. Radiobiological considerations in the design of fractionation strategies for intensity-modulated radiation therapy of head and cancers. Int J Radiat Oncol Biol Phys 46 (2000) 619-630
25. Mohan R., Zhang X., Dong L., et al. Use of deformed intensity distributions for on-line modification of image-guided IMRT to account for interfractional anatomic changes. Int J Radiat Oncol Biol Phys 61 (2005) 1258-1266
26. Nieuwenhuis E.J.C., van der Wall I., and Leemans C.R. Histopathologic validation of the sentinel node concept in oral and oropharyngeal squamous cell carcinoma. Head Neck 27 (2005) 150-158
27. Paulino A.C., Koshy M., Howell R., Schuster D., and Davis L.W. Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer. Int J Radiat Oncol Biol Phys 61 (2005) 1385-1392
28. Teo P.M., Ma B.B., and Chan A.T. Radiotherapy for nasopharyngeal carcinoma-transition from two-dimensional to three-dimensional methods. Radiother Oncol 73 (2004) 163-172
29. Werner J.A., Dünne A.A., and Ramaswamy A. The sentinel node concept in head and neck cancer: solution for the controversies in the N0 neck?. Head Neck 26 (2004) 603-611